Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

Posted on Categories: Investor Relations

Vancouver, BC, July 14, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Acreage Pharms Ltd. (“Acreage Pharms”) located near Edson, Alberta, utilizing a multi-room indoor perpetual growing methodology, will begin its first harvest the first week of August, with the second harvest occurring the following week. The company anticipates a harvest to take place approximately monthly going forward.

Invictus MD is further pleased to announce that Acreage Pharms has received its development permit for Phase 2 and has broken ground initiating construction on its 27,800 square foot purpose built, multiple room production facility. All contractors and suppliers necessary for the project have been scheduled. Invictus MD has committed to investing $6.0 million, which will be used to fund the costs of constructing the production facility.

Read more “Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update”

Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.

Posted on Categories: Investor Relations

Vancouver, BC, July 13, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to provide an update that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), AB Laboratories Inc. (“AB Labs”) located in Hamilton, Ontario, utilizing a multi-room indoor perpetual growing methodology, completed its first harvest four weeks ago, with the second harvest occurring this week. The company anticipates a harvest to take place approximately monthly going forward. The first two crops consisted of a number of batches of strain offerings with varying THC/CBD concentrations.

AB Ventures Inc. (“AB Ventures”), an incorporated company formed to develop a second licensed expansion facility through its common ownership with AB Labs, is forging ahead with planning its Phase 1 expansion which initially includes the development of two 21,000 square foot, multiple room production facilities. AB Ventures is planning to construct additional production facilities on its 100 acres of land totaling 100,000 square feet. Building plans have been completed and a development advisor has been engaged to provide guidance at the pre-consultation stage towards its site plan approval.

Read more “Invictus MD Provides a Corporate Update on AB Laboratories Inc. and AB Ventures Inc.”